प्रशांत टंडन, टाटा 1mg के सह-संस्थापक और सीईओ हैं, जो भारत का सबसे बड़ा डिजिटल हेल्थ प्लेटफॉर्म है। वह 2009 से भारतीय डिजिटल हेल्थकेयर के अग्रणी उद्यमियों में से एक रहे हैं। उन्होंने 1mg और हेल्थकार्ट जैसी उद्योग-परिभाषित कंपनियों की सह-स्थापना की और उनका नेतृत्व किया है। इस विशेष बातचीत में, डॉ. सौम्या सिंह, क्रिएटिव एडिटर, उनसे डिजिटल हेल्थ प्लेटफॉर्म्स और ई-फार्मेसी की परिवर्तनकारी भूमिका पर चर्चा कर रही हैं।

1. ई-फार्मेसी का विकास और दवाओं की पहुँच में बदलाव

ई-फार्मेसी ने हाल के वर्षों में जबरदस्त वृद्धि दर्ज की है। डिजिटल हेल्थ प्लेटफॉर्म्स ने दवाओं तक पहुँच और डिलीवरी की प्रक्रिया में क्रांतिकारी बदलाव किए हैं। उन्होंने स्वास्थ्य सेवाओं को सुलभ, किफायती, सुविधाजनक और आरामदायक बनाया है। उपभोक्ता मोबाइल ऐप या वेबसाइट पर प्रिस्क्रिप्शन अपलोड करके आसानी से दवा मंगवा सकते हैं। यह सुविधा विशेष रूप से ग्रामीण क्षेत्रों में रहने वाले लोगों, बुजुर्गों और नियमित दवा रीफिल की आवश्यकता वाले मरीजों के लिए सहायक है।

इन प्लेटफॉर्म्स के जरिए विभिन्न भौगोलिक क्षेत्रों में दवाओं की उपलब्धता सुनिश्चित होती है। साथ ही लैब टेस्ट और टेली-कंसल्टेशन जैसी सेवाएँ भी शामिल की जा रही हैं। दवा वितरण पूरी तरह से डिजिटल रूप से ट्रैक और ट्रेस किया जाता है, जिससे सुरक्षा और पारदर्शिता बढ़ती है। मरीजों को दवाओं की कीमत, उपलब्धता और विकल्पों की जानकारी भी आसानी से मिलती है।

2. उपभोक्ताओं को सशक्त बनाने में डिजिटल प्लेटफॉर्म्स की भूमिका

डिजिटल हेल्थ प्लेटफॉर्म्स उपभोक्ताओं को दवाओं से जुड़ी जानकारी, लक्षण जांच (symptom checkers), शैक्षणिक सामग्री, और विशेषज्ञ परामर्श उपलब्ध कराते हैं। मरीज अपॉइंटमेंट बुक कर सकते हैं, अपने स्वास्थ्य डेटा का प्रबंधन कर सकते हैं और दवा/चेकअप रिमाइंडर प्राप्त कर सकते हैं।

वेयरेबल टेक्नोलॉजी के इंटीग्रेशन से उपभोक्ता अपने वाइटल साइन और एक्टिविटी लेवल मॉनिटर कर सकते हैं। साथ ही, लेख, वीडियो और वेबिनार जैसी सामग्री उन्हें जागरूक बनाती है। कम्युनिटी फोरम और सपोर्ट ग्रुप्स मरीजों को अनुभव साझा करने और समर्थन पाने का अवसर देते हैं, जिससे निवारक स्वास्थ्य प्रबंधन को बढ़ावा मिलता है।

3. एंटीमाइक्रोबियल रेजिस्टेंस (AMR) और डिजिटल हेल्थ

AMR एक वैश्विक चुनौती है। डिजिटल हेल्थ प्लेटफॉर्म्स जिम्मेदार एंटीबायोटिक उपयोग को सुनिश्चित करने में अहम भूमिका निभा रहे हैं।

• हर दवा वितरण का डिजिटल रिकॉर्ड होता है।
• प्लेटफॉर्म्स यह सुनिश्चित करते हैं कि एंटीबायोटिक केवल प्रिस्क्रिप्शन पर ही उपलब्ध हों।
• उपभोक्ताओं को AMR के खतरों और दवा का पूरा कोर्स पूरा करने की महत्ता पर शिक्षित किया जाता है।
• डॉक्टरों को डिसीजन सपोर्ट टूल्स उपलब्ध कराए जाते हैं, ताकि एंटीबायोटिक सही तरीके से लिखी जाएं।
• डेटा एनालिटिक्स के माध्यम से गलत उपयोग के पैटर्न पहचाने और नियंत्रित किए जाते हैं।

4. ई-फार्मेसी में आर्टिफिशियल इंटेलिजेंस (AI) का प्रयोग

AI ने ई-फार्मेसी की सेवाओं को और बेहतर बनाया है:

• मरीजों के हेल्थ प्रोफाइल और पूर्व व्यवहार पर आधारित पर्सनलाइज्ड सिफारिशें।
• AI चैटबॉट्स के जरिए तुरंत ग्राहक सेवा।
• इन्वेंटरी मैनेजमेंट में प्रेडिक्टिव एनालिटिक्स से मांग का सटीक पूर्वानुमान।
• ड्रग इंटरैक्शन चेक्स के जरिए सुरक्षित दवा संयोजन।
• डेटा साइंस मॉडल्स से हाथ से लिखे प्रिस्क्रिप्शन को डिजिटाइज करना।

5. ऑनलाइन दवा बिक्री पर नियामक चुनौतियाँ

भारत में ई-फार्मेसी अभी Drugs & Cosmetics Act 1945, IT Act और अन्य नियमों के तहत काम करती है। हालांकि, अब एक एकीकृत और आधुनिक कानून की ज़रूरत है। प्रस्तावित Drugs and Medical Devices Act में ऑनलाइन बिक्री को विशेष रूप से शामिल किया गया है।

6. नकली दवाओं की रोकथाम

ई-फार्मेसी नकली दवाओं से निपटने में बेहतर स्थिति में है क्योंकि:

• पूरी सप्लाई चेन एंड-टू-एंड ट्रैसेबल है।
• केवल प्रमाणित निर्माताओं और अधिकृत वितरकों से ही दवाएँ खरीदी जाती हैं।
• बारकोड और ट्रैकिंग सिस्टम्स से हर स्टॉक की निगरानी होती है।
• नियमित ऑडिट और क्वालिटी चेक्स किए जाते हैं।

7. ई-फार्मा इंडस्ट्री की चुनौतियाँ

मुख्य चुनौतियाँ:

• अलग-अलग कानूनों और विभागों के बीच समन्वय की कमी।
• लेवल प्लेइंग फील्ड का अभाव – ओपन मार्केट में बिना प्रिस्क्रिप्शन दवाएँ मिल जाती हैं।
• डेटा प्राइवेसी और सिक्योरिटी की बढ़ती आवश्यकताएँ।

डिजिटल हेल्थ प्लेटफॉर्म्स इन चुनौतियों को सुरक्षित आईटी इंफ्रास्ट्रक्चर, ब्लॉकचेन, AI और रेगुलेटरी सहयोग से हल कर रहे हैं।

8. अगली डिजिटल क्रांति

भविष्य की डिजिटल हेल्थक्रांति में AI, मशीन लर्निंग और IoMT (Internet of Medical Things) का एकीकरण होगा। यह तेज़ और सटीक डायग्नोस्टिक्स, पर्सनलाइज्ड ट्रीटमेंट, और इंटरऑपरेबिलिटी सुनिश्चित करेगा।

9. पर्सनलाइज्ड मेडिसिन और टेलीमेडिसिन

डिजिटल प्लेटफॉर्म्स जेनेटिक, पर्यावरणीय और जीवनशैली डेटा पर आधारित व्यक्तिगत इलाज मुहैया कराएंगे। टेलीमेडिसिन के जरिए मरीजों को वर्चुअल केयर, रिमोट मॉनिटरिंग और घरेलू स्वास्थ्य सेवाएँ उपलब्ध होंगी।

10. डेटा प्राइवेसी और सिक्योरिटी

• एन्क्रिप्शन, मल्टी-फैक्टर ऑथेंटिकेशन और सिक्योर स्टोरेज।
• नियमित सिक्योरिटी ऑडिट।
• डेटा हैंडलिंग में पारदर्शिता और कर्मचारियों का प्रशिक्षण।

11. सहयोग और साझेदारियाँ

• फार्मास्युटिकल कंपनियों के साथ सहयोग से सप्लाई चेन और बेहतर।
• टेक्नोलॉजी कंपनियों के साथ AI आधारित सेवाएँ।
• शैक्षणिक संस्थानों के साथ शोध साझेदारी।

12. भविष्य की दृष्टि

भारत के पास अवसर है कि वह ग्लोबल साउथ के लिए मॉडल बनाए। भविष्य की ई-फार्मेसी केवल दवा वितरण तक सीमित न होकर टेलीमेडिसिन, डायग्नोस्टिक्स, पर्सनल हेल्थ गाइडेंस और इंटीग्रेटेड हेल्थ मैनेजमेंट प्लेटफॉर्म्स के रूप में विकसित होगी।

डिजिटल हेल्थ प्लेटफॉर्म्स व्यक्तिगत, सुलभ, पारदर्शी और मरीज-केंद्रित स्वास्थ्य सेवा सुनिश्चित करेंगे, जिससे न केवल भारत बल्कि दुनिया के कई हिस्सों में स्वास्थ्य सेवाओं में क्रांति आएगी।

The post स्वास्थ्य सेवाओं में क्रांति: ई-फार्मेसी और डिजिटल हेल्थ प्लेटफॉर्म्स का भविष्य appeared first on InnoHEALTH magazine.

According to the WHO, Stress is simply a state of worry or mental tension that we experience during difficult times. However, it is a natural human response that lets us tackle various situations in our lives. Everyone experiences it, whether it happens to be in life, work or the overuse of digitalisation accompanied by a bunch of notifications. There is no doubt that each of us is looking for a breather.

So, in this field of stress, technology holds a revolutionary role of being a complete package. It is like a legit ally with wearable devices for stress relief, stress management apps, and many more. That is all here to help you out with the release of stress hormones like norepinephrine, adrenaline and cortisol.

Adopting a smart yet healthy lifestyle, Almost 66% of users rely on mobile apps to take care of their health. It covers everything from stress levels to blood sugar levels and online consultations.

From a market perspective, the global wearable technology market is rapidly growing. Its 2024 estimates were about USD 84.2 billion, and in the future, it is anticipated to grow with an annual growth rate of 13.6 % from 2025 to 2030. This shows how the rising concerns of mental health and chronic diseases are advancing the adoption of body monitors or stress trackers.

So, if you are searching for advanced wearable devices for stress relief, this list of such advanced techniques is all here to help you out. Make a worthy investment that helps you promote the production of stress-relieving hormones.

Top Advances in Mental Health Technology and Trends

As technology is not limited to making you smart, it can also contribute to making your lifestyle healthier. Especially when there are plenty of resources that are becoming reasons for stress. These technically advanced digital mental health solutions are here to help. Some of them are mentioned below:

Stress Management Apps

You may have seen or used food delivery apps or other related apps, but when it comes to stress management, there are also effective options for this niche. In this advanced digital era, you can find a wide range of such apps, from general stress relief apps to meditation apps, that can relieve stress to a certain level.

What They Do

Such apps guide you to adopt healthy habits, offer bite-sized sessions to meditate and suggest breathing exercises.

A study by JMIR Mental Health analysed that the regular use of stress apps for 30 days can reduce stress by 15-20%.

Virtual Reality for Mental Health

Stress and anxiety issues are the most common mental health conditions in the current times, where it is majorly affecting adults. However, while there are many solutions, Virtual Reality in mental health is also considered an effective approach.

What They Do

VR is all about making you feel like experiencing reality with the help of some smart devices like headsets or others. These VR works on creating relaxing environments, simulates scenarios in a controlled way and can integrate cognitive behavioural therapy. With the use of this technique, in just six weeks, patients dealing with stress and phobia witnessed a 75% reduction in symptoms.

Wearable Devices for Stress Relief

There is a lot about technology to digest, right? Whether it is about advanced AI techniques to many other smart accessories. In all, such wearable techniques are not just limited to step counts. These stress relief products keep tabs on your heart rate variability (HRV), which is a standard term for the stress-handling capacity of your heart. Also, many such devices work on vagus nerve stimulation to promote relaxation and calm the nerves system.

What They Do

Analysing these health factors provides insight and preventive measures for reducing stress. Harvard Health Publishing presents claims about wearable devices reducing stress quickly with the Vagus nerve stimulation technique. Check out similar wearable devices for stress relief at Ubuy to invest in a healthy lifestyle.

AI Chatbot for Stress Relief

The recent chatbot trends might be focusing on creating Ghibli image art, but AI is way more than this when it comes to AI in medical innovations. In other words, AI is getting in on action in this field by introducing chat therapy.

What They Do

These AI chatbots use Cognitive-Behavioural-Therapy techniques to talk to users who are facing stress. They feature 24/7 availability, easy accessibility, guided exercises, initiate personalised conversations and avail mood tracking. According to the research findings, patients with depression and anxiety experienced a 51% and 31% reduction of symptoms, respectively, with the chatbot therapy.

The Tech Flip-Flop or Duality Challenge

It is said that too much of anything is bad, and even the excessive use of technology can lead to stress. Currently, we are all at a stage of a tipping point, where the overuse of technology can backfire. The refreshing use of X or other social media platforms can spike anxiety, especially with doomscrolling. In that case, balance is the only key to surviving in such advancements.

Follow these tips to access a healthy lifestyle.

• Keep your digital use limited and interact with useful resources.
• Try not to scroll unthinkingly and use digital app trackers or time limiters.
• Keep yourself updated with stress management apps or wearable reports.
• Celebrate your achievements, even if it is about smiling after so long.

Technology has opened a new frontier in the mental health care field. Digital mental health solutions like smartphone apps or wearable devices provide a revolutionised way to deal with stress and other related issues. These solutions can be very simple but effective in many ways. For instance, anyone with such devices can call, text, or chat at any time to ease any difficult situation caused by stress.

These technical advancements are way more, what we think and are not just limited to productivity or following the trend; feeling better needs to be a priority, too. So just let an app guide your breathing, a bot lend an ear to your insecurities, and a smartwatch track your stress levels, because in the end, it is all about you living your life, not others.

Authors Biography

Fahad Khan is a Product Manager and digital marketing enthusiast who works at Ubuy Technologies. Content marketing, PPC, email, and social media marketing are among his areas of expertise. He has been exploring the field of digital marketing to share his pearls of wisdom with the whole world. He enjoys working on different niches and creating valuable content for readers.

The post Advances in Mental Health: Technology’s Role in Stress Management appeared first on InnoHEALTH magazine.

1. E-pharmacy has seen significant growth in recent years. Can you share your insights on how digital health platforms are revolutionizing the way medicines are accessed and delivered to consumers?
   E-pharmacies have significantly enhanced accessibility, affordability, convenience & comfort while empowering customers with useful information to manage their healthcare better. We let customers request medicines by uploading a prescription through a convenient app/ website and have them delivered to their homes. This service is especially helpful for people who live in rural places, elderly people who have mobility problems, or need to get prescription refills on a regular basis. Also, many times medicines are not easily available in one geography, while they may be available in other locations – a digital platform manages to ensure better availability of medicines as needed by consumers. Laboratory tests and Teleconsultations are also integrated into digital health systems, further empowering patients’ access to medical consultations. These developments ensure better prescription adherence and speed up obtaining medications. Digital health platforms enhance full transparency and safety in medication delivery, given everything is end to end tracked and traced. Also, they offer detailed information on drug availability, pricing, and alternatives, allowing consumers to make informed choices. Additionally, the well organized platforms incorporate stringent verification processes and quality checks to ensure that medications are genuine and safe. By analyzing patient data, these platforms can provide dosage reminders, health tips and even managed care programs, improving overall health outcomes.
   
   
2. How do digital health platforms leverage their platform to empower users in making informed decisions about their health, accessing healthcare services, and adopting preventive healthcare measures?
   Platforms for digital health give consumers access to a multitude of information from around the world, and use that for empowering our customers with deeper knowledge. These services provide detailed information of the medicines patients are taking and many other health related information such as – symptom checks, instructional materials, and guidance from medical specialists. They let users schedule appointments, manage their health data, and get reminders for things like medicine and checkups. Users may monitor vital signs and activity levels by incorporating wearable technology, which promotes proactive health management. Educational content, including articles, videos, and webinars on various health topics, keeps users informed and engaged. Additionally, community forums and support groups allow users to share experiences, seek advice, and gain support from peers facing similar health challenges promoting preventive health.
   
   
3. Antimicrobial resistance (AMR) is a growing concern globally. How do you see digital health platforms playing a role in addressing AMR, particularly in ensuring responsible antibiotic use and promoting awareness among consumers?
   Digital health platforms play a crucial role in combating AMR. Given that every dispensation is tracked digitally end to end, it is much easier to ensure proper Antibiotic adherence through digital platforms. Ideally, all Antibiotic dispensation should be on similar platforms only, to ensure there is no self medication and prescription abuse for antibiotics. Also, the platforms play a role towards promoting responsible antibiotic use and increasing awareness in both the patients and doctors associated with their platforms. Educational content about the dangers of AMR and the importance of completing antibiotic courses is readily available to consumers. Moreover, these platforms can be leveraged to track antibiotic prescriptions and usage patterns, providing data that can be analyzed to identify and mitigate misuse trends. Digital health platforms can integrate decision support tools for healthcare professionals to aid in antibiotic prescribing. This data-driven approach aids in developing targeted interventions to curb AMR. Platforms should use their reach and influence to advocate for policy changes and investments in AMR prevention and control.
   
   
4. Artificial intelligence (AI) is increasingly being integrated into e-pharmacy platforms to enhance services and improve efficiency. Can you discuss some of the AI-driven innovations implemented to enhance user experience and optimize healthcare outcomes?
   AI enhances e-pharmacy services by improving accuracy, efficiency, and user experience. AI algorithms personalize medication recommendations based on individual health profiles and past behaviors. Chatbots powered by AI provide instant customer service, answering queries and guiding users through the purchasing and delivery process. AI-driven predictive analytics help manage inventory by forecasting demand, reducing the likelihood of stockouts or overstocking. Furthermore, AI applications in drug interaction checks ensure safe medication combinations, enhancing patient safety. We are also working upon data science models which can digitize typewritten and handwritten health records, which again can serve the ecosystem beyond just pharmacies.
   
   
5. The online sale of medicines has been subject to regulatory scrutiny in many countries, including India. What are your thoughts on potential new regulations governing the online sale of medicines, and how do you foresee these regulations impacting the e-pharma industry?
   A lot of controversy around online pharmacies in many countries pertains to cross border trade of medicines, for which many countries have regulated that online pharmacies have to be domiciled within the country only. Also, today China, Europe, Latin America, USA – all have ePharmacies thriving. Especially post covid, the need for a national digital infrastructure to access medication is well recognized. In India, presently, all dispensation is governed by the Drugs & Cosmetics Act & Rules 1945, and players fully comply with those provisions. In addition, the players need to comply with IT Act and other rules governing retail and eCommerce. However, we do feel the time has come for the country to have an integrated and updated set of rules, given that today the models are governed under multiple Acts and harmonizing them will ensure much better ease of doing business. Also, the various upcoming innovative models at play may have specific requirements. The impending new Drugs and Medical Devices Act has already mentioned online sales of medicines would be specifically addressed. We will continue our engagements with the regulators to help frame comprehensive sectoral guidelines that ensure the safe and efficient operation of e-pharmacies.
   
   
6. What steps do online platforms typically implement to prevent the sale of counterfeit medications?
   ePharmacies are fundamentally well positioned to ensure accountability in the supply chain, since all medicines are end-to-end trackable and traceable here from supplier to patient, unlike in the open market where a lot of such medicines are dispensed without a clear traceability, often involving cash transactions. Digitization of the supply chain is the largest weapon in the fight against counterfeit, and the ePharmacy model naturally has that advantage. Also, given all transactions come with an invoice, there is proper accountability of various players embedded in the system, besides better tax realization for the government. Additionally, ePharmacies implement several measures to prevent the sale of counterfeit medications. All good ePharmacies have a robust partner onboarding mechanism in place. They source products directly from reputed manufacturers and authorized distributors, which is critical towards ensuring the authenticity of stock. Advanced tracking systems and barcoding technology enable traceability from the distributor to the consumer. ePharmacies also perform regular audits and quality checks, and take consumer feedback seriously for end to end checks.
   
   
7. What are some of the key challenges facing the e-pharma industry, and how are digital health platforms addressing these challenges to ensure compliance, safety, and quality in the delivery of healthcare services?
   The key challenge for the ePharmacy industry today is around ease of doing business. All players have to comply with various laws and rules which come under various acts, and many times a single department is not aware of the other laws governing the ecosystem. For example, it is commonly seen that a local Drug Inspector is not aware of the IT Act, Consumer Protection Act or eCommerce rules, and it is a cumbersome process to respond to various issues that may come up. Also, there is a need for a level playing field, and it is well known that prescription requirements, presence of pharmacists and other regulations are often not equally imposed. As a result, a lot of customers on ePharmacy platforms are disappointed that we seek prescriptions when they easily get the same medicines without in the open market. Another challenge is around ensuring data security, and with the upcoming data privacy laws, there is a need to set up adequate systems to manage that. Digital health platforms address these challenges by investing in secure, scalable IT infrastructure and adopting comprehensive compliance protocols. They collaborate with regulatory bodies to stay updated on regulations and adapt practices accordingly. To ensure product authenticity, e-pharmacies partner with companies and their authentic vendors, leverage advanced technologies like blockchain and AI for supply chain management and verification. Continuous stakeholder engagement and user education and transparent operations build consumer trust and ensure quality service delivery. Digital health platforms prioritize data privacy and security by implementing robust encryption protocols, access controls, and data anonymization techniques to protect patient information.
   
   
8. With the rapid advancement of technology, what do you envision as the next digital revolution in the healthcare industry, and how do you see digital health platforms adapting to and driving this transformation?
   The next digital revolution in healthcare will involve the integration of advanced AI, machine learning, and the Internet of Medical Things (IoMT). These technologies will enable more precise and faster diagnostics, personalized treatment plans taking into account health data and real time wearable data, and seamless interoperability among different healthcare systems. Digital health platforms will likely evolve to offer holistic health management ecosystems, integrating fitness, nutrition, mental health, and medical care into a single user interface. This transformation will enhance preventive care, early detection of diseases, and patient engagement. 
   
   
9. Personalized medicine and telemedicine are emerging trends in healthcare. How do you see digital health platforms evolving to incorporate these trends into their service offerings, and what opportunities do they present for improving patient care?
   Personalized medicine and telemedicine may be driven faster by and also effectively integrated into digital health platforms, providing customized healthcare solutions that consider genetic, environmental, and lifestyle aspects. Genetic data will be used by platforms to offer individualized medication recommendations and health guidance. The field of telemedicine is expected to grow, offering a wide range of virtual care solutions such as digital treatments, remote monitoring, and expert consultations. Opportunities to enhance patient outcomes, lower healthcare costs, and broaden access to high-quality treatment are presented by these trends. Resultant Chronic disease management programs, virtual care solutions, remote patient monitoring and home healthcare will lead to better health outcomes. 
   
   
10. Data privacy and security are critical considerations in the digital health space. How do digital health platforms ensure the confidentiality and integrity of user data while leveraging data analytics to enhance their services?
    To ensure data privacy and security, digital health platforms implement robust cybersecurity measures, including encryption, secure data storage, and multi-factor authentication. They adhere to regulations like national data protection laws to safeguard user data. Regular security audits, employee training on data privacy, and transparent data handling practices enhance trust. 
    
    
11. Collaboration and partnerships are essential for the success of digital health platforms. Can you share some examples of successful collaborations undertaken to expand reach and enhance service offerings?
    Partnerships with academic institutions, technology businesses, pharmaceutical companies, and healthcare providers are some of the key digital health collaborations. Partnerships with pharmaceutical firms, for instance, can increase medicine availability and optimize supply chains and improve access to patient support programs. By using cutting-edge technologies like artificial intelligence, partnerships with tech companies can improve platform capabilities. Innovation in digital health solutions is being fostered through cooperative research collaborations with academic institutions. These alliances broaden their clientele, improve the services they provide, and propel the sector forward.
    
    
12. Finally, what is your vision for the future of e-pharmacy and digital health, and how do you see these platforms contributing to the advancement of healthcare delivery and accessibility?
    India today has an opportunity to create the new model of digital access to healthcare, which is not only a model for India but for the entire global south. Digital Health platforms hold the promise of making healthcare personalized, integrated, accessible and affordable – and in all these dimensions India is well endowed to lead the world in creating the new age model and technology. E-pharmacy and digital health will prosper in the future when state-of-the-art technology is combined with a patient-first mentality. E-pharmacies are now transforming into all-inclusive health management platforms that provide a variety of services, including telemedicine, diagnostics services, personalized health advice, and pharmaceutical delivery. E-pharmacy and digital health platforms have the potential to transform by delivering personalized and precision healthcare, empowering patients, promoting collaborative care models, expanding access and equity, and driving continuous innovation and collaboration across the healthcare ecosystem. By leveraging technology, data-driven insights, and collaborative partnerships, these platforms can contribute to a future where healthcare is accessible, equitable, and patient-centered, ultimately improving the health and well-being of individuals and communities. By increasing efficiency, personalization, and accessibility, digital health platforms will play an integral part in improving healthcare delivery.

The post Revolutionizing Healthcare: Insights into the Future of E-Pharmacies and Digital Health Platforms appeared first on InnoHEALTH magazine.

In the rapidly evolving landscape of digitalization, where every online interaction leaves behind a trail of personal information, we find ourselves at a pivotal juncture. Our personal data, a highly sought-after asset in the digital era, is constantly in demand by various entities. However, within this frenzy of data collection lies an exceptionally intimate and personal treasure trove – our health data. As we embark on an innovative journey through India’s Digital Personal Data Protection Bill 2023, it becomes imperative for healthcare professionals to comprehend how this legislation may safeguard our most invaluable possession: our health data.

The Paradigm Shift:

Close your eyes for a moment and envision this scenario: you visit a doctor for a routine check-up, sharing your medical history, undergoing tests, and receiving a diagnosis. But have you ever paused to ponder what happens to that information once you leave the doctor’s office? In many instances, it transforms into a digital fragment, residing in a vast repository accessible to various parties. It could be used for research, become a tool for insurance companies, or, in the worst-case scenario, fall prey to malicious data breaches. Often, we place our trust in healthcare providers, assuming they will protect this sensitive information. But is trust alone sufficient in these turbulent digital waters?

Another distressing facet of this clandestine industry is the unauthorized access to health data by unscrupulous actors.

Data Protection Bill 2023: A Beacon of Hope:

The Digital Personal Data Protection Bill 2023 in India emerges as a beacon of hope in our mission to preserve the sanctity of our health data. Let’s embark on an enlightening journey to explore some of its key provisions and their potential impact on our lives:

1. Personal Consent: This legislation stipulates that personal data can only be processed for lawful purposes with explicit consent from the individual. In simpler terms, your health data remains concealed from prying eyes unless you choose to disclose it. This provision empowers you with newfound control over your data.
2. Data Accuracy and Security: The Bill places the responsibility on data fiduciaries, those who collect and process data, to maintain the integrity of the data, ensuring its security and deletion once its intended purpose is fulfilled. It establishes a fundamental principle: the safeguarding of your health data is paramount.
3. Individual Rights: Within this framework, you are granted the right to access information about how your data is being processed, the ability to correct inaccuracies, and a mechanism to address concerns. This provision fosters a culture of transparency and accountability, putting you in charge of your health data’s fate.
4. Cross-Border Data Transfer: In a world where data flows across borders rapidly, the Bill introduces regulations governing the transfer of personal data beyond India’s shores. This safeguard ensures that your health data doesn’t inadvertently end up in countries lacking robust data protection standards.
5. Data Breach Reporting: In the unfortunate event of a data breach that could jeopardize your well-being, data fiduciaries are obligated to report it to the Data Protection Board of India and directly inform you. This measure ensures timely awareness and empowers you to take corrective action.

Why Does it Matter?

Our health data, a digital reflection of our most private and intimate aspects, holds the potential to revolutionize medical research, enable personalized therapy, and potentially save lives. However, this promise is not without risks, especially in a society where data has become a valuable commodity. The Digital Personal Data Protection Bill 2023 acts as a formidable deterrent against the latent threats of health data misuse and breaches.

Unmasking the Shadows: Crimes in Health Data Industry in India

A formidable industry has thrived in the shadows of the digital world, operating away from the public eye. This shadowy domain revolves around the illicit exchange and exploitation of health data, a sector worth billions of dollars. It thrives on the unauthorized acquisition of individuals’ medical information, often without their knowledge.

For too long, India’s health data industry has functioned as a clandestine network. It’s a hidden realm where people’s private lives, medical conditions, treatments, and vulnerabilities are commodified and auctioned off to the highest bidder. This profession is rife with a range of undisclosed crimes, including data theft, sales, unauthorized access, and extortion.

One glaring example of these crimes involves the widespread sale of health data to insurance companies. Imagine a scenario where an individual, dealing with a severe illness, confides in their healthcare provider. Little do they know that this information could end up in the hands of insurance companies looking to deny coverage or inflate premiums. This surreptitious trade in health data not only jeopardizes individuals’ financial well-being but also erodes the trust placed in the healthcare system.

Digital Personal Data Protection Bill 2023 has the potential to shine a spotlight on this clandestine business, exposing its wrongdoings and guaranteeing the utmost respect and protection for individuals’ health data.

Another distressing facet of this clandestine industry is the unauthorized access to health data by unscrupulous actors. Medical records, often stored in digital repositories, become prime targets for hackers seeking to exploit vulnerabilities in security systems. These cybercriminals gain access to sensitive patient information, which can be used for identity theft, fraudulent insurance claims, or even sold on the black market.

Furthermore, healthcare institutions themselves are not immune to these crimes. Incidents of data breaches within hospitals and clinics are alarmingly common. Patient records, filled with personal identifiers, become the currency of the illicit health data trade. In many cases, these breaches go undisclosed, leaving patients unaware of the compromise of their personal information.

In a world where our health data is digitized and shared, the need for robust data protection measures becomes undeniable. This is precisely where the Digital Personal Data Protection Bill 2023 in India steps in as an agent of change. It has the potential to expose the shadowy actors in the health data industry, bringing them to justice and ensuring the privacy and dignity of individuals’ health data.

One of the key provisions of the Bill is its stringent stance on data breaches. It mandates that data fiduciaries promptly report breaches to the Data Protection Board of India and the affected individuals. This requirement ensures transparency and accountability in the event of a breach, making it significantly more challenging for wrongdoers to operate covertly.

In conclusion, India’s health data industry, shrouded in secrecy, has thrived for too long on the vulnerabilities of individuals and the absence of robust data protection measures. The Digital Personal Data Protection Bill 2023 has the potential to shine a spotlight on this clandestine business, exposing its wrongdoings and guaranteeing the utmost respect and protection for individuals’ health data. As custodians of health information, healthcare professionals must play a pivotal role in advocating for data privacy and urging the implementation of the Bill’s requirements. In doing so, we can pave the way for India’s genuine progress, where our most personal data is safeguarded, and the shadows of the health data industry are dispelled by the light of transparency and accountability. This is how India can truly thrive as a developed nation while preserving the well-being and dignity of its people.

“Composed by: Sagar Pandya is a highly accomplished professional with a Master’s degree in Software Technology and a decade long experience in the software industry, working with renowned multinational corporations, gaining expertise in latest technologies. He is also an author, known for his book “Tales of the Jungle: Fables of Indian Animals and Morals.”

The post India’s 1.4 Billion Health Data Mavericks:Awakening Awareness in a Nation that Takes it Easy appeared first on InnoHEALTH magazine.

“We are moving into a bold era, defined by advanced medical technologies and artificial intelligence. But healthcare will always remain a human business”. For Dominic Asquith, British High Commissioner to India that is the crux of the current situation, but a razor-sharp competitive business in medical devices across the world has a different narrative because of market compulsions vis-a-vis human business.

India’s strong position on heart stents’ price regime triggered debate and the price war snowballed into tough positions and international players gaped with bewilderment. Many institutions and professional bodies flew into action and debated price structures while the country’s federal government unveiled its world’s largest health coverage scheme for millions, virtually creating a colossal potential in the health sector. If the government extends healthcare services to its 1.25 billion population as part of India’s Universal Health Coverage (UHC) agenda, it will be a challenge to devise ways to reduce catastrophic Out Of Pocket (OOP) expenditure on healthcare and ensure affordable access to essential healthcare for the entire population with the limited resource envelope.

Amid ongoing trading tussle between US and China, many apprehend that ripple effect will also percolate down in India as the latter is going ahead with its price regimes and its moves to bring down stent and knee implant devices had raised many eyebrows.

A section of media has reported that AdvaMed (Advanced Medical Technology Association)in its briefing memo for US Commerce Secretary and US Trade Representative last year had conveyed that “Made in India” scheme has been used by parts of the Indian government to justify protectionist measures such as import tariff hike sand preferential market access policies.

The Economist newspaper recently carried a write-up which quoted China Digital times, a California based website, that Chinese media had been advised to play down China’s global dominance in various technological sectors, known as “Made in China 2025”.Such developments indicate that India should also dial down the hype on “Made in India”.

The 2014 World Bank Report estimated the OOP spending on healthcare in India to be as high as 89%. India is the only country, out of the major world economies, where out-of-pocket expenses are increasing, despite a concurrent increase in public spending. This effectively means that more people are availing private healthcare services due to rising incomes or are forced to spend due to inadequate public expenditure.

Official sources say big schemes can be ensured with the help of Health Technology Assessment (HTA), which is a widely used methodology internationally for optimization of resource allocation in health. HTA is a method of evidence synthesis that considers aspects pertaining to clinical effectiveness, cost-effectiveness, social, ethical and legal implications of the use of “health technology” for healthcare intervention.

The Indian healthcare industry was valued at over USD 100 billion in 2016 and is expected to reach more than USD175 billion by 2020, resulting in a CAGR (Compound Annual Growth Rate) of 20%. The medical device industry is valued at USD 6 billion. The medical device industry was accorded the status of an independent industry in 2014. The medical device sector today is clearly small and indicates low penetration in the country.

“The path to realizing healthcare goals is complex, and various fundamental issues and challenges need to be addressed and solved holistically. Long-term plans need periodic policy and regulatory interventions to ensure fair conduct within the industry while providing the support needed for profitable and sustainable growth. These activities will enable the medical device industry to accelerate rapidly and play a key role in making India healthier and stronger.” Mr. Guljit Singh, Executive Chairman of SKP Business and Abby Pratt, Vice President for Global Strategy and Analysis at AdvaMed said in their forward of the study. AdvaMed had partnered last year with SKP to publish the study entitled – Medical Device Industry in India –the evolving landscape, opportunities, and challenges.

The study also examined various policies and regulations impacting the industry and attempts to make recommendations on the way forward from the perspective of different stakeholders.

The study made a slew of recommendations like cap trade margins and not price to the dealers, should be capped after a detailed evaluation of each medical device segment and the role of trade. Trade margins should be fixed differentially for different categories of devices, based on service requirements and role of distributors.

It says allow the dealers to compete with each other and provide a fair price to the hospitals based on the terms and conditions of services and payments. There is a need to work towards bundled payment models as used in many other countries to better align incentives for hospitals and their business models. Increase government healthcare spending as a percentage of GDP; India lags behind the other BRICS in this regard.

Adequate utilization of government infrastructure to reduce the cost to private players – PPP model could be an attractive alternative to explore. Specify certain quantities/ proportions of supply of different stents at lower prices to specified government agencies for use with underprivileged sections. It advocated to empower the Medical Technology Assessment Board (MTAB) to evaluate the model of tiered pricing as observed in the French healthcare ecosystem, wherein the NPPA caps the generic products and leaves the latest generation products with incremental value out of the ‘essentiality purview’.

The incremental value could be on account of efficacy, material used, ease of delivery and shortened recovery time. Various combinations are possible here such as: an increase in the number of tiers, allowing new introductions to be free of price intervention for a certain number of years. Identify priority medical devices and procedures that demonstrate the greatest need stemming from disease burden. MTAB, alongwith other regulators for medical devices, should ensure that there are minimum quality parameters – in terms of safety, clinical efficacy, and cost-effectiveness – for medical devices that get used in the public and private health system, such that long-term costs are lowered over a patient’s lifespan, with need for fewer hospital readmissions, lowered need for medication, and overall better health outcomes.

The report said factors such as changing demographics, rising life expectancy, growing incomes and public awareness have contributed to a higher demand for medical care. A more focused approach from the government, with increased public expenditure on health, greater utilization of technology, vibrant private sector participation, and continued innovation can transform the sector and move India closer to its goal of providing quality universal healthcare.

Some of the key issues faced by the Indian healthcare industry are evident: with India’s disease burden shifting from acute to chronic diseases, large number of the population continue to not have access to basic healthcare services. Public health infrastructures are poorly equipped to deal with this shift towards NCDs.

While the government and value chain participants are undertaking several steps to address these issues, they have been executed in silos. Medical service providers are not only inadequate but are also not evenly distributed across rural and urban areas. This shortfall occurs despite an increase in the number of medical colleges from 23 in 1947 to 398 in 2014. The quality and availability of healthcare deteriorate as one moves away from large urban centers to lower-tier towns and rural areas. The Indian medical device industry, the report found, is highly fragmented. Currently, these sectors are dominated by MNCs with 70-75% of the demand being met through imports.

Approximately 30% of the domestically manufactured devices are exported, in which the consumables and disposables segment has the largest share.

On a mix of technologies such as engineering, electronics, material sciences and information technology – innovation, capital and technology drive the industry. However, India has not been able to bridge the gap between investments, skilled resources, and innovation to fully capitalize on these opportunities. Numerous factors underlie the prevalence of higher imports in the country.

Some of these are: no clear comparative cost advantage in view of other emerging markets; policy issues like inverted duty structured do not help in creating a positive environment; lack of favorable policy and regulatory framework, the report, compiled last year said.

On segments, the study said, hearing aids and pacemakers form major part of patient aid segment and constitute 70% of the segment collectively. Most of the products are sourced from Australia, China, Ireland, Singapore, South Korea and US.

The medical disposables and consumables sector consists of products such as plastic syringes, blood bags and many others. This segment is dominated by domestic players in India due to its low technology requirements. Needles and syringes constitute majority of the sales. However, wound management products and medical apparels are the fastest growing products in this segment. The Indian implants segment has witnessed an encouraging growth rate of CAGR 25%.

With a healthy mix of both domestic companies and MNCs, this segment has witnessed intense competition between players due to strong pricing pressure. The domestic players have realized the market potential which demands customization and differentiated product quality. The equipment and instruments section is the largest segment of the medical device industry constituting nearly 54% of the segment and is dependent on imports.

MRI machines, CT scanners, ultrasound machines, dental drills, dental chairs, dental x-ray machines are some of the key products of this segment. It is dominated by MNCs like GE Healthcare, Philips Healthcare, Schiller Healthcare, Danaher Corporation, and Roche.

Drug-eluting stents and bare metal stents form a major part of the stents segment and constitute more than 70% of the segment collectively. Most products are sourced from US and Europe. While domestic companies are manufacturing cost-competitive products, they still face competition from international players on account of quality. Diagnostics segment is growing due to advanced technology being increasingly applied in medical procedures.

The report had said government initiatives control regulation and the new Public Procurement Policy- the Preferential Market Access – do not fully reflect this and has alarmed many industry participants.

A clear long-term vision and roadmap for the industry and predictability of policy would excite the industry. The government needs to provide policy support for both the supply and demand side of the medical device industry to successfully accelerate growth. Industry and government need to work together to improve awareness, access has made rapid progress in the last decade, but significantly lags behind other nations in availability and quality of equitable medical care and services for citizens.

This, in turn, presents an enormous opportunity given the large population, growing economic prosperity, and the disease burden. Major issues such as availability of adequate infrastructure, trained human resources, geographic spread, rapidly changing disease burden, and high/often catastrophic out of pocket expenditures are challenges that the government is keen to address, the report said.

The Indian government is committed to raise public expenditure on health to 2.5% of the GDP. Public and private sectors need to play equally important but different roles in bringing rapid change to the healthcare scenario in the coming decade.

Around opening up, FDI and infrastructure development are welcome initiatives that will enhance the ecosystem for investment. The Indian medical device industry appreciates government’s efforts to remove bureaucratic hurdles and improve the ease of doing business, but believes that additional steps can be taken to strengthen its approach.

The study identified challenges and said growth in the healthcare industry has been attractive. However, much more needs to be done. Despite the advent of private players and better government spending, most Indians can only afford and/or have access to basic healthcare. Hence, the path to universal healthcare coverage is challenging.

Some of the obstacles faced are – real estate prices and high capital costs limit the growth of delivery infrastructure; insufficient attention by policymakers and a complex tax regime are also responsible for the sector’s underdevelopment; the lack of a comprehensive policy and focus to develop the healthcare ecosystem; low penetration: the per capital medical device spending of USD 3 compared to USD 7 in China and USD 42 in Russia is significantly low.

Another study early this year – “Medical devices in India – an agenda to effective healthcare delivery” said to attract world’s top med-tech players to establish their research and development (R&D) operations in the country and to establish a firm footing in the global market, the Government needs to adopt a robust policy and regulatory framework. India can replicate some of the models being adopted by other nations that have succeeded in attracting leading medical players. The contents of this report are based on a study commissioned by AdvaMed and conducted by IQVIA on behalf of AdvaMed.

It said that the government can provide financial incentives in form of extended tax holidays or weighted tax reduction for R&D investments; boost local demand for medical devices by stepping up public healthcare spending which in-turn could catalyze investments in this sector. Further, the government should focus on creating an enabling regulatory landscape by creating a separate legislation system for medical devices.

The report said while, Medical Devices Rules 2017 is a welcome step towards regulating the medical devices sector, the setting up separate notified body and distinct legislation system for devices with a focus on the following could further boost growth of the industry like Grant product approvals; Instituting quality standards; Setting up monitoring mechanisms for devices; Expedite patent approval process for medical devices.

Medical devices form more than USD 200-billion global industry, which develops and manufactures essential healthcare equipment. The Indian industry is currently valued at USD 4.4 billion with about 700 medical device makers, India’s medical device market is currently the fourth-largest in Asia (after Japan, China and South Korea) and ranks among the world’s top 20.

Imports constitute a substantial part of the medical device market in India. An estimated 80% of India’s demand for medical devices is currently met by imports, nearly 30% of which are supplied by the US. Imported medical devices are often those that are critical, innovative and high-risk in nature – either life-saving or life-enabling, and therefore undergo rigorous testing. These complex, innovative devices are designed to address the growing expectations of India’s population in the country’s rapidly evolving healthcare system, this report said.

The medical device industry has been very encouraged by the Prime Minister’s recognition of the critical role of medical devices in addressing India’s healthcare challenges. The Adva Medwebsite says in general, we have a received a strong message from the government that they are interested in promoting the medical devices sector and creating an environment that fosters innovation. This is great news not only for manufacturers of medical devices but more importantly for patients who desperately need access to high quality yet affordable lifesaving and life-enhancing medical technologies.

The PM’s call to medical device manufacturers is a welcome recognition of this separate and important part of the healthcare system. Several of AdvaMed’s member companies have already established manufacturing units in India, and India is being increasingly viewed as an R&D base.

The website says, the medical device industry in India has grappled with challenges for several years around recognition and regulation. While the Global Medical Device Nomenclature (GMDN) lists more than 14,000 different product types, the current regime only regulates a relatively modest portion of these products.

Moreover, these devices/products are regulated as “drugs” under the Drugs and Cosmetics Act of 1940. This is problematic because medical devices are very different from drugs in terms of diversity, product development, patent structures, types of failures, scientific disciplines involved in assessing performance/efficacy.

In addition to the arbitrary application of the rules for drugs to medical devices, which hinders the development, quality of and access to medical devices, there is also a lack of predictability in the regulatory system. The industry is also concerned about the lack of standardization in line with global best practices.

The post Medical Devices in India Witness Churning appeared first on InnoHEALTH magazine.

The post Innovative imaging solutions by Philips appeared first on InnoHEALTH magazine.